Schering-Plough CapEx increased by 312.2% to $676.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 312.2%, from $164.00K to $676.00K.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $497.75K | $497.75K | $497.75K | $497.75K | $164.00K | $676.00K |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -67.1% | +312.2% |
| YoY Change | — | — | — | — | -67.1% | +312.2% |